AVANTOR INC

NYSE: AVTR (Avantor, Inc.)

Last update: 3 days ago, 7:36AM

12.31

-0.70 (-5.38%)

Previous Close 13.01
Open 13.00
Volume 6,186,403
Avg. Volume (3M) 12,841,320
Market Cap 8,392,207,360
Price / Earnings (TTM) 12.19
Price / Earnings (Forward) 12.44
Price / Sales 1.26
Price / Book 1.34
52 Weeks Range
10.83 (-12%) — 27.83 (126%)
Earnings Date 31 Oct 2025
Profit Margin 10.70%
Operating Margin (TTM) 8.21%
Diluted EPS (TTM) 1.04
Quarterly Revenue Growth (YOY) -5.90%
Quarterly Earnings Growth (YOY) 6.80%
Total Debt/Equity (MRQ) 67.34%
Current Ratio (MRQ) 1.12
Operating Cash Flow (TTM) 808.50 M
Levered Free Cash Flow (TTM) 751.08 M
Return on Assets (TTM) 3.53%
Return on Equity (TTM) 12.52%

Market Trend

Short Term Medium Term
Industry Medical Instruments & Supplies (US) Mixed Bearish
Medical Instruments & Supplies (Global) Mixed Bearish
Stock Avantor, Inc. Bearish Bearish

AIStockmoo Score

-1.0
Analyst Consensus -0.5
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages -3.5
Technical Oscillators -0.5
Average -1.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
AVTR 8 B - 12.19 1.34
BDX 55 B 1.08% 35.08 2.10
RMD 40 B 0.39% 28.53 6.65
WST 16 B 0.28% 34.84 6.22
BLCO 5 B - - 0.840
ALC 43 B 0.35% 38.45 1.75

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Sector Healthcare
Industry Medical Instruments & Supplies
Investment Style Mid Core
% Held by Insiders 1.35%
% Held by Institutions 103.17%

Ownership

Name Date Shares Held
New Mountain Capital, L.L.C. 30 Jun 2025 14,000,000
Clarkston Capital Partners, Llc 30 Jun 2025 13,982,090
Robeco Schweiz Ag 30 Jun 2025 8,727,184
52 Weeks Range
10.83 (-12%) — 27.83 (126%)
Price Target Range
12.00 (-2%) — 17.00 (38%)
High 17.00 (RBC Capital, 38.10%) Buy
Median 14.00 (13.73%)
Low 12.00 (Morgan Stanley, -2.52%) Hold
12.00 (Stifel, -2.52%) Hold
Average 14.33 (16.41%)
Total 7 Buy, 2 Hold
Avg. Price @ Call 11.30
Firm Date Target Price Call Price @ Call
Baird 04 Aug 2025 15.00 (21.85%) Buy 11.30
28 Jul 2025 18.00 (46.22%) Buy 13.99
Barclays 04 Aug 2025 13.00 (5.61%) Buy 11.30
Evercore ISI Group 04 Aug 2025 16.00 (29.98%) Buy 11.30
JP Morgan 04 Aug 2025 14.00 (13.73%) Buy 11.30
Morgan Stanley 04 Aug 2025 12.00 (-2.52%) Hold 11.30
RBC Capital 04 Aug 2025 17.00 (38.10%) Buy 11.30
Raymond James 04 Aug 2025 14.00 (13.73%) Buy 11.30
Stifel 04 Aug 2025 12.00 (-2.52%) Hold 11.30
Wells Fargo 04 Aug 2025 16.00 (29.98%) Buy 11.30

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria